To the Editor:— The article by Allen and Murphy inThe Journal, April 16, page 1759, on the use of beta-propiolactone for the sterilization of instruments and materials omits a very important consideration in the use of this substance. Beta-propiolactone is a carcinogen. Local sarcomas have been produced by subcutaneous injection of beta-propiolactone in rats (Walpole and others:Brit. J. Pharmacol.9:306 [Sept.] 1954), and squamous papillomas and squamous carcinomas have been produced in mice by painting the skin with this material (Roe and Glendenning:Brit. J. Cancer10:357 [June] 1956). In the laboratory of Dr. Paul Kotin we have produced sarcomas and squamous papillomas in mice by a single subcutaneous injection of a minute amount (.002 ml.) of beta-propiolactone (recent unpublished data). This information is brought to the attention of the readers ofThe Journalso that it may be more widely disseminated.
No takes yet. Share an insight, caveat, or question.
Dean V. Wiseley (1960) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: